2019冠状病毒病信使核糖核酸疫苗接种与心肌炎或心包炎 - Suppr

Suppr

超能文献

COVID-19 mRNA vaccination and myocarditis or pericarditis.

作者信息

Husby Anders, Køber Lars

机构信息

Department of Epidemiology Research, Statens Serum Institut, Copenhagen DK-2300, Denmark.

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Lancet. 2022 Jun 11;399(10342):2168-2169. doi: 10.1016/S0140-6736(22)00842-X.

DOI:10.1016/S0140-6736(22)00842-X

PMID:35691306

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9183212/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/9183212/8bd54b4ff5d6/fx1_lrg.jpg

相似文献

COVID-19 mRNA vaccination and myocarditis or pericarditis.

Lancet. 2022 Jun 11;399(10342):2168-2169. doi: 10.1016/S0140-6736(22)00842-X.

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.

Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022.

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.

Ann Acad Med Singap. 2022 Feb;51(2):96-100. doi: 10.47102/annals-acadmedsg.2021425.

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.

BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.

Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?

Expert Rev Cardiovasc Ther. 2022 Feb;20(2):87-90. doi: 10.1080/14779072.2022.2044305. Epub 2022 Feb 25.

Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.

Expert Rev Vaccines. 2022 Nov;21(11):1691-1696. doi: 10.1080/14760584.2022.2100765. Epub 2022 Jul 25.

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.

MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1.

Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines.

Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):99-103. doi: 10.1093/ehjqcco/qcab090.

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination.

JAMA Netw Open. 2022 Jun 1;5(6):e2218512. doi: 10.1001/jamanetworkopen.2022.18512.

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.

BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223.

引用本文的文献

Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.

Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.

Regulation of protein thermal stability and its potential application in the development of thermo-attenuated vaccines.

Eng Microbiol. 2024 Jun 25;4(3):100162. doi: 10.1016/j.engmic.2024.100162. eCollection 2024 Sep.

A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety.

Bioact Mater. 2024 May 14;38:486-498. doi: 10.1016/j.bioactmat.2024.05.012. eCollection 2024 Aug.

MRI of cardiac involvement in COVID-19.

Br J Radiol. 2024 Aug 1;97(1160):1367-1377. doi: 10.1093/bjr/tqae086.

Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models.

Nat Commun. 2024 Jan 18;15(1):590. doi: 10.1038/s41467-024-44830-1.

Eur J Med Res. 2024 Jan 2;29(1):2. doi: 10.1186/s40001-023-01569-7.

The Serum ACE2, CTSL, AngII, and TNFα Levels after COVID-19 and mRNA Vaccines: The Molecular Basis.

Biomedicines. 2023 Nov 27;11(12):3160. doi: 10.3390/biomedicines11123160.

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

EClinicalMedicine. 2023 Sep 12;64:102168. doi: 10.1016/j.eclinm.2023.102168. eCollection 2023 Oct.

How prevalent is COVID-19 vaccine hesitancy in low-income and middle-income countries and what are the key drivers of hesitancy? Results from 53 countries.

BMJ Open. 2023 Nov 6;13(11):e069152. doi: 10.1136/bmjopen-2022-069152.

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.

Lancet Respir Med. 2023 Nov;11(11):975-990. doi: 10.1016/S2213-2600(23)00263-1. Epub 2023 Sep 13.

本文引用的文献

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.

Lancet. 2022 Jun 11;399(10342):2191-2199. doi: 10.1016/S0140-6736(22)00791-7.

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.

JAMA Cardiol. 2022 Jun 1;7(6):600-612. doi: 10.1001/jamacardio.2022.0583.

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis.

Lancet Respir Med. 2022 Jul;10(7):679-688. doi: 10.1016/S2213-2600(22)00059-5. Epub 2022 Apr 11.

Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis.

J Pediatr. 2022 Jun;245:233-237. doi: 10.1016/j.jpeds.2022.03.032. Epub 2022 Mar 26.

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

JAMA. 2022 Jan 25;327(4):331-340. doi: 10.1001/jama.2021.24110.

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study.

Ann Intern Med. 2022 Mar;175(3):362-370. doi: 10.7326/M21-3700. Epub 2022 Jan 25.

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.

BMJ. 2021 Dec 16;375:e068665. doi: 10.1136/bmj-2021-068665.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.

Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.

N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.

N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验